After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Sanofi (SNY) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.10, or -0.21%, to $46.93. The Sanofi has recorded 5,897 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
SNY belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $47.03 and fluctuated between $47.80 as its day high and $46.97 as its day low. The current market capitalization of Sanofi is $118.86B. A total of 1.54 million shares were traded on the day, compared to an average of 1.98M shares.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Sanofi pays an annual dividend of $1.90, resulting in a dividend yield of 4.05%, and it has a price to earnings (P/E) ratio of 13.35. SNY’s most recent ex-dividend date was 5/30/2023 when it declared a $1.3770 quarterly dividend that was paid in cash on 6/23/2023. Previously, the company paid the dividend on 6/8/2022 with an ex-dividend date of 5/4/2022. The SNY stock dividend was $1.7968 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for SNY in the last 3 months, the mean price target is $56.55 with high estimates of $64.39 and low estimates of $45.42. In terms of 52-week highs and lows, SNY has a high of $57.79 and a low of $36.91.
As of this writing, SNY has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0. The company reported an EPS of $1.44 in the last quarter, which was 7.50% higher than expectations of $1.34.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 22 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SNY is Sell with a score of 4.14. A total of 13 analysts rated the stock as Buy while 1 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
